Drug Controller General permits clinical trial of convalescent plasma in COVID-19 patients
Posted by
www.biotecnika.org
The central drug regulator has given its go-ahead to a proposal by the
Indian Council of Medical Research for the clinical trial of
convalescent plasma in COVID-19 patients, as per the protocol
developed by ICMR.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-controller-general-permits-clinical-trial-of-convalescent-plasma-in-covid-19-patients/articleshow/75216853.cms
Subscribe to:
Post Comments (Atom)
Post a Comment